MedPath

analgesic effects of ketamine-propofol and ketamine-sufentanil

Phase 2
Conditions
Acute lymphoblastic leukaemia [ALL].
Acute lymphoblastic leukemia [ALL]
Registration Number
IRCT20170809035601N6
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
68
Inclusion Criteria

children between 6 month and 14 years old
Candid bone marrow aspiration and lumbar Puncture

Exclusion Criteria

Hypersensitivity or allergic reaction to any medication regimen
The use of analgesic and anesthetic ago
Cardiovascular disease, respiratory disease, liver disease, epilepsy or a history of seizures, neurological disorders, brain tumor or metastasis.
There are chronic pain syndromes.
Head injuries

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath